FENC logo

FENCFennec Pharmaceuticals Inc

$8.70
$0.46
(5.02%)
Today
Closed $8.70
$0.00
(0.00%)
After Hours
Updated: 05:55 PM EDT
Reported EarningsMay 14
Mkt Cap$302.21M
Vol169,981.00
News
all
press releases
Do Options Traders Know Something About Adherex Technologies Stock We Don't?
Investors need to pay close attention to FENC stock based on the movements in the options market lately.
Zacks
News Placeholder
More News
News Placeholder
Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates
Adherex Technologies (FENC) delivered earnings and revenue surprises of +157.14% and +8.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
MaxCyte (MXCT) delivered earnings and revenue surprises of +57.90% and +31.31%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates
Iovance Biotherapeutics (IOVA) delivered earnings and revenue surprises of 0.00% and -7.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Adherex Technologies (FENC) Expected to Announce Quarterly Earnings on Tuesday
Adherex Technologies (NASDAQ:FENC) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-fennec-pharmaceuticals-inc-stock...
MarketBeat
News Placeholder
Insider Selling: Adherex Technologies (NASDAQ:FENC) Director Sells 10,781 Shares of Stock
Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) Director Rosty Raykov sold 10,781 shares of the business's stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $6.47, for a total value of $69,753.07. Following the sale, the director owned...
MarketBeat
News Placeholder
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven research firms that are presently covering the stock...
MarketBeat
News Placeholder
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below Fifty Day Moving Average - Here's What Happened
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below Fifty Day Moving Average - What's Next...
MarketBeat
News Placeholder
Adherex Technologies (NASDAQ:FENC) Given "Outperform" Rating at Wedbush
Wedbush reiterated an "outperform" rating and issued a $13.00 target price on shares of Adherex Technologies in a research note on Thursday...
MarketBeat
News Placeholder
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below Fifty Day Moving Average - What's Next?
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below Fifty Day Moving Average - Here's What Happened...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.